Health Canada puts on hold drug ID rule for combination devices
This article was originally published in RAJ Devices
Executive Summary
Health Canada has decided to put on hold a new product licensing requirement under which manufacturers of medical devices with a drug component were required to provide the Drug Identification Number (DIN) of the product’s medicinal component to establish that it meets acceptable standards of safety, efficacy and quality1.